Stephen Mitchener Net Worth & Insider Trades

Stephen Mitchener - SVP, Karyopharm Therapeutics Inc

As of March 2, 2023

What is Stephen Mitchener's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's SVP, Stephen Mitchener, is estimated to be about $29.62K . Stephen Mitchener owns about 128,313 units of Karyopharm Therapeutics Inc common stock. In the last 2 years at Karyopharm Therapeutics Inc, Stephen Mitchener has sold an estimated value of $27.5K worth.

What is Stephen Mitchener's Past Insider Trading?

Stephen Mitchener's largest sale order was 6,357 units , worth over $19.26K on March 2, 2023. In total, Stephen Mitchener has made about 6 transactions over 2 years of their time at Karyopharm Therapeutics Inc. Stephen Mitchener usually trades in June and March, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Stephen Mitchener

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Stephen Mitchener's' Mailing Address?

  • Mailing address is C/o Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 MA

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on December 5, 2023 by Richard Paulson who sold 3,622 units worth $2.86K . In the last 10 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $148.24M and bought an estimated value of $33.49M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...